UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares rose more than 5% to about $397 on Thursday after Bank of America upgraded the stock to ‘Buy,' citing improving medical cost trends and a more favorable risk-reward setup heading into upcoming earnings. The firm also raised its price target to $450 and lifted earnings estimates for 2026 and 2027.